Email
Password
Remember meForgot password?
    Log in with Twitter

Glaxosmithkline News

Google and GSK team up for multimillion bioelectronics project

London - Big name companies Google and GlaxoSmithKline have entered into a joint venture to develop bioelectronics. The emerging field is set to be the next big thing in health care.

Op-Ed: Ads you can talk to? IBM’s Watson vs online marketing

Sydney - If you, like the rest of the human race, are less than thrilled with online ads, and even less impressed with their targeting, things may be about to change. IBM's cognitive system Watson is about to "humanize" online advertising.

GSK sets out to help low income countries

London - In a bid seemingly to help poorer nations, drugs giant GlaxoSmithKline has said it will not file patents for drugs in the world's poorest countries to improve access to its products in the developing world.

Head of GSK to retire, and other pharma news

The head of GlaxoSmithKline is to retire, amid some concerns about the company’s performance. Digital Journal presents this and other news from the pharmaceutical sector, including mergers and FDA warnings.

GSK fined for making deals with competitors

London - Pharmaceutical company GlaxoSmithKline (GSK), together with several generics companies, has been fined for being anti-competitive and keeping the price of an anti-depressant drug artificially high.

Canadian women file class-action lawsuit over anti-nausea drug

A class-action lawsuit has been filed in Canada by women who say their babies were harmed after the women took a powerful anti-nausea drug that was not technically approved for use during their pregnancies.

GlaxoSmithKline continues restructuring, cuts 900 jobs

GlaxoSmithKline (GSK) is eliminating 900 U.S. jobs. Most of these losses are in R&D. Furthermore, some employees may be relocated to other facilities.

Pharmaceutical firm dumps polio virus into Belgium river

Rixensart - Staff working at a GlaxoSmithKline (GSK) facility dumped more than 45 liters of concentrated live polio into the water at a Belgian treatment plant earlier this month.

Glaxo receives record fine in China

Changsha - The Chinese government has fined U.K. pharmaceuticals giant GlaxoSmithKline $490 million (3 billion yuan) after a court found the firm guilty of bribery.

Pandemrix H1N1 vaccine and narcolepsy

A study linking GlaxoSmithKline’s Pandemrix H1N1 vaccine to the sleep disorder has been pulled from the literature. Researchers argued that the sleep disorder might result from an immune reaction against the wakefulness-regulating hormone hypocretin.

GlaxoSmithKline asks for regulatory approval of malaria vaccine

Researchers at GlaxoSmithKline believe they have finally developed an effective vaccine for Malaria. Now they need government approval to finish and deploy the latest version.

Sex tape adds to GSK-China corruption case

GlaxoSmithKline (GSK) continues to deal with the ramifications of a massive corruption scandal in China. To add to this the drug company has confirmed the existence of a "sex tape" involving former China head, Mark Reilly, and a Chinese woman.

Poland extends corruption probe into Britain's GSK

Warsaw - Polish prosecutors said Monday they have extended a probe into allegations that British pharmaceutical giant GlaxoSmithKline bribed doctors into promoting one of its drugs.

Britain's GSK reveals new bribery probe in Iraq

London - British drugmaker GlaxoSmithKline (GSK) is investigating alleged corruption by staff at its pharmaceuticals division in Iraq, the group announced on Monday.

UK drugs firm GSK announces Africa investment

London - British pharmaceutical giant GlaxoSmithKline on Monday announced a five-year investment programme for sub-Saharan Africa to fuel the company's growth and to serve an area with "pressing health needs".

GlaxoSmithKline vaccine suspended in Portugal

The National Agency for Medicines and Health Products of Portugal decided to suspend the administration of British vaccine maker GlaxoSmithKline's vaccine Infanrix Tetra following the report of adverse reactions.

GSK pays $1 bn to increase stake in Indian pharmaceutical unit

London - GlaxoSmithKline has lifted its stake in the group's Indian subsidiary to 75 percent, the British drugmaker said on Monday.GSK said in a statement that it had increased its stake in publicly-listed GlaxoSmithKline Pharmaceuticals Limited from 50.7 perce...

GSK brushes off China probe to post solid 2013 profits

London - GlaxoSmithKline's net profits jumped by a fifth in 2013 as lower taxes offset flat sales, announced on Wednesday the British drugmaker hit by a bribery probe in China.Earnings after tax rallied almost 21 percent to £5.4 billion ($8.8 billion, 6.

GSK bribing medics with cash and 'sexual favors' (update)

'Big Pharma' company GSK is accused of bribing to government officials, doctors, hospitals and industry associations using travel agencies as conduits for the cash in China. China also states that sexual favors were offered as bribes.

Op-Ed: Big Pharma just as bad as it looks, says new global study

Sydney - The howls from the public have been loud and long, but the pharmaceutical industry just isn’t listening. A new international study has confirmed a common urban myth- This bloodsucking, endlessly sued industry is just as bad as critics claim.

GlaxoSmithKline loses appeal in French 'gay sex addict' case

A Frenchman suffering from Parkinson's disease who claimed he developed addictions to gambling and sex following treatment with a drug made by pharmaceutical giant GlaxoSmithKline (GSK), has been awarded substantial damages.

GlaxoSmithKline fined $3 billion for pharmaceutical fraud

The pharmaceutical company GlaxoSmithKline has been ordered pay $3 billion in fraud charges, the largest sanction of its kind in US history.

Review: 'The Truth About Tax' or bashing big business? Special

On Monday night, the BBC's 'Panorama' programme featured an hour long investigation into how hundreds of big companies avoid paying their fair share of tax, but are they really the bad guys?

Glaxo to invest in UK following tax break

London - The 'big pharma' giant GlaxoSmithKline has announced that it will take advantage of a UK tax break and invest heavily in the UK to the tune of $800 million. This reverses a trend of larger pharmaceutical corporations leaving the UK.

FDA approves Benlysta, first Lupus drug in over fifty years

Rockville - The Food and Drug Administration announced its approval of the intravenous drug Benlysta, to treat patients with active auto-antibody-positive lupus, making it the first new drug approved for the debilitating condition since the 1950's.

Pharmaceutical Chicanery: Snake Oil Vendors of the Modern Era

Are you sure you know what you are getting inside that box of prescription medicine? Two recent newspaper articles have offered very interesting and varying perspectives into a disturbing growing international trend in the pharmaceutical industry.

GlaxoSmithKline Q4 profits up 66% from H1N1 vaccines

H1N1 swine flu vaccine maker GlaxoSmithKline released its fourth quarter profits today. The company's profits are $2.6 billion. The boost comes from Swine Flu vaccine purchases.

GlaxoSmithKline and Others to Donate Avian Flu Virus

GlaxoSmithKline, Sanofi-Aventis, Baxter International Inc and Omnivest will all provide vaccine in order to create a global stockpile of human vaccine for H5N1 bird flu, The World Health Organization has announced.
 

Search Digital Journal Archives


Set up a news alert for

Glaxosmithkline


Glaxosmithkline Image

GlaxoSmithKline Headquarters  Brentford  UK
GlaxoSmithKline Headquarters, Brentford, UK
Google Streetview
GlaxoSmithKline headquaters in Brentford  London  England
GlaxoSmithKline headquaters in Brentford, London, England
Maxwell Hamilton

Latest News
Top News